REQUEST A DEMO
Total
USD $0.00
Search more companies

Innoclinica Cia.Ltda (Ecuador)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Psychiatric and Substance Abuse Hospitals
Full name: Innoclinica Cia.Ltda Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Innoclinica Cia.Ltda is an enterprise in Ecuador, with the main office in Quito. The company operates in the General Medical and Surgical Hospitals sector. Innoclinica Cia.Ltda was incorporated on June 09, 2017. 21 (2024) employees currently work for Innoclinica Cia.Ltda. In 2024, the company reported a net sales revenue increase of 88.14%. Over the same period, its total assets grew by 46.83%. In 2024, Innoclinica Cia.Ltda’s net profit margin increased by 2.1%.

Headquarters
Av. Mariana de Jesus Oe7-02, Citimed Bldg.
Quito; Pichincha;

Contact Details: Purchase the Innoclinica Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Innoclinica Cia.Ltda report to view the information.
Registered Capital:
Purchase the Innoclinica Cia.Ltda report to view the information.
Financial Auditors:
Purchase the Innoclinica Cia.Ltda report to view the information.
Incorporation Date:
June 09, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Innoclinica Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
88.14%
Total operating revenue
105.91%
Operating profit (EBIT)
332.53%
EBITDA
182.06%
Net Profit (Loss) for the Period
935.57%
Total Assets
46.83%
Total Equity
22.02%
Operating Profit Margin (ROS)
2.63%
Net Profit Margin
2.1%
Return on Equity (ROE)
-26.1%
Quick Ratio
0.09%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?